{"article_link": "https://doi.org/10.1038/s41586-021-04278-5", "data": [{"id": "data_1", "omics": "Genomics", "link": "https://ega-archive.org/studies/EGAS00001004582", "format": "fastq", "source": "European Genome-Phenome Archive (EGA)", "public_id": "EGAS00001004582"}, {"id": "data_2", "omics": "Genomics", "link": "https://ega-archive.org/studies/EGAS00001004582", "format": "vcf", "source": "European Genome-Phenome Archive (EGA)", "public_id": "EGAS00001004582"}, {"id": "data_3", "omics": "Transcriptomics", "link": "https://ega-archive.org/studies/EGAS00001004582", "format": "fastq", "source": "European Genome-Phenome Archive (EGA)", "public_id": "EGAS00001004582"}, {"id": "data_4", "omics": "Transcriptomics", "link": "https://ega-archive.org/studies/EGAS00001004582", "format": "tpm", "source": "European Genome-Phenome Archive (EGA)", "public_id": "EGAS00001004582"}, {"id": "data_5", "omics": "Digital Pathology", "link": "", "format": "tiff", "source": "Internal repository", "public_id": ""}], "analyses": [{"id": "analysis_1", "analysis_type": "Differential gene expression analysis", "analysis_data": ["data_3", "data_4"], "training_set": [], "test_set": [], "label": {"Response": ["pCR", "Residual Disease"]}, "features": ["TP53", "PIK3CA", "CCNE1", "MYC", "ESR1", "ERBB2", "CDKN2A", "EGFR"]}, {"id": "analysis_2", "analysis_type": "Gene set enrichment analysis (MSigDB Hallmarks)", "analysis_data": ["data_4"], "training_set": [], "test_set": [], "label": {"Response": ["pCR", "Residual Disease"]}, "features": ["Proliferation", "Immune activation", "APOBEC signature", "IFNγ response", "MTORC1 signaling"]}, {"id": "analysis_3", "analysis_type": "Copy number calling (QDNAseq)", "analysis_data": ["data_1", "data_2"], "training_set": [], "test_set": [], "label": {"Response": ["pCR", "Residual Disease"]}, "method": "Ordinal logistic regression"}, {"id": "analysis_4", "analysis_type": "Mutational signature decomposition (DeconstructSigs)", "analysis_data": ["data_2"], "training_set": [], "test_set": [], "label": {"Response": ["pCR", "Residual Disease"]}, "features": ["APOBEC signature", "HRD signature"]}, {"id": "analysis_5", "analysis_type": "HLA typing and neoantigen calling", "analysis_data": ["data_1", "data_4"], "training_set": [], "test_set": [], "label": {"Response": ["pCR", "Residual Disease"]}, "features": ["HLA LOH", "Neoantigen binding affinity"]}, {"id": "analysis_6", "analysis_type": "iC10 classification", "analysis_data": ["data_1", "data_4"], "training_set": [], "test_set": [], "label": {"Response": ["pCR", "Residual Disease"]}, "features": ["iC10 subtypes (e.g., iC10, iC3, iC7, iC8)"]}, {"id": "analysis_7", "analysis_type": "Machine learning ensemble model", "analysis_data": ["data_1", "data_2", "data_3", "data_4", "data_5"], "training_set": [], "test_set": [], "label": {"Response": ["pCR", "Residual Disease"]}, "features": ["Age", "Lymphocyte density", "PGR", "ERBB2", "TMB", "Chromosomal instability"], "description": "External validation cohort (n=75 patients from ARTemis and PBCP studies)"}, {"id": "analysis_8", "analysis_type": "Gene set variation analysis (GSVA)", "analysis_data": ["data_4"], "training_set": [], "test_set": [], "label": {"Response": ["pCR", "Residual Disease"]}, "features": ["GGI score", "STAT1 immune signature"]}, {"id": "analysis_9", "analysis_type": "TIDE algorithm", "analysis_data": ["data_4"], "training_set": [], "test_set": [], "label": {"Response": ["pCR", "Residual Disease"]}, "features": ["T cell dysfunction", "T cell exclusion"]}], "results": [{"analysis_id": "analysis_1", "metric": "p-value", "value": {"TP53": "0.01", "PIK3CA": "0.002", "CCNE1": "0.001", "MYC": "0.0005", "ESR1": "0.003", "ERBB2": "0.0001", "Fold Change (FC)": "1.5-2.0"}, "features": ["TP53", "PIK3CA", "CCNE1", "MYC", "ESR1", "ERBB2", "CDKN2A", "EGFR"]}, {"analysis_id": "analysis_2", "metric": "Normalized enrichment score", "value": "-2 to 2", "features": ["Proliferation", "Immune activation", "APOBEC signature", "IFNγ response", "MTORC1 signaling"]}, {"analysis_id": "analysis_3", "metric": "Monotonic association (ordinal logistic regression)", "value": "P = 0.0002", "features": ["Copy number alterations", "Chromosomal instability"]}, {"analysis_id": "analysis_4", "metric": "Monotonic association", "value": "P = 0.00001", "features": ["HRD signature", "APOBEC signature"]}, {"analysis_id": "analysis_5", "metric": "Binding affinity score", "value": "< 500 nM", "features": ["HLA LOH", "Neoantigen binding affinity"]}, {"analysis_id": "analysis_6", "metric": "Overrepresentation", "value": "Pearson residuals", "features": ["iC10 subtypes (iC10, iC3, iC7, iC8)"]}, {"analysis_id": "analysis_7", "metric": "AUC", "value": "0.87", "features": ["Age", "Lymphocyte density", "PGR", "ERBB2", "TMB", "Chromosomal instability"]}, {"analysis_id": "analysis_8", "metric": "GSVA score", "value": "High (above mean)", "features": ["GGI score", "STAT1 immune signature"]}, {"analysis_id": "analysis_9", "metric": "T cell dysfunction/exclusion", "value": "Increased in RCB-III", "features": ["T cell dysfunction", "T cell exclusion"]}]}